Boehringer Mannheim ordered into arbitration with Ostex International:
This article was originally published in Clinica
Executive Summary
US District Court judge Barbara Rothstein has ordered Boehringer Mannheim to participate in arbitration proceedings initiated by Ostex International. The dispute between the two companies concerns Ostex' termination of a distribution, R&D and licence agreement with Boehringer for the osteoporosis test Osteomark (see Clinica No 684, p 11).